USEMX
Price
$26.49
Change
-$0.04 (-0.15%)
Updated
Nov 19 closing price
Net Assets
634.1M
VEIEX
Price
$34.03
Change
-$0.05 (-0.15%)
Updated
Nov 19 closing price
Net Assets
141.19B
Interact to see
Advertisement

USEMX vs VEIEX

Header iconUSEMX vs VEIEX Comparison
Open Charts USEMX vs VEIEXBanner chart's image
Victory Emerging Markets
Price$26.49
Change-$0.04 (-0.15%)
VolumeN/A
Net Assets634.1M
Vanguard Emerging Mkts Stock Idx I
Price$34.03
Change-$0.05 (-0.15%)
VolumeN/A
Net Assets141.19B
USEMX vs VEIEX Comparison Chart in %
View a ticker or compare two or three
VS
USEMX vs. VEIEX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is USEMX is a Hold and VEIEX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEIEX has more cash in the bank: 141B vs. USEMX (634M). VEIEX pays higher dividends than USEMX: VEIEX (2.61) vs USEMX (2.38). USEMX was incepted earlier than VEIEX: USEMX (31 years) vs VEIEX (32 years). USEMX (1.56) is less costly to investors than VEIEX (0.29). USEMX is a more actively managed with annual turnover of: 74.00 vs. VEIEX (8.00). VEIEX has a lower initial minimum investment than USEMX: VEIEX (0) vs USEMX (3000). USEMX annual gain was more profitable for investors over the last year : 30.49 vs. VEIEX (20.18). USEMX return over 5 years is better than : 37.76 vs. VEIEX (23.38).
USEMXVEIEXUSEMX / VEIEX
Total Expense Ratio1.520.29524%
Annual Report Gross Expense Ratio1.560.29538%
Fund Existence31 years32 years-
Gain YTD31.99022.205144%
Front LoadN/AN/A-
Min. Initial Investment30000-
Min. Initial Investment IRAN/AN/A-
Net Assets634M141B0%
Annual Yield % from dividends2.382.6191%
Returns for 1 year30.4920.18151%
Returns for 3 years62.5647.23132%
Returns for 5 years37.7623.38162%
Returns for 10 years98.4278.61125%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CUE0.58N/A
+0.02%
Cue Biopharma
RNGR13.51N/A
N/A
Ranger Energy Services
MTSR70.50N/A
N/A
Metsera Inc
CHPGU10.26N/A
N/A
Championsgate Acquisition Corp
TRVI11.05-0.26
-2.30%
Trevi Therapeutics